(Q38936705)

7 September 2017

1 reference

title

Immunogenic Apoptotic Cell Death and Anticancer Immunity (English)

1 reference

7 September 2017

0 references

3

Claus Bachert

1 reference

7 September 2017

Peter Vandenabeele

1

1 reference

ORCID Public Data File 2021

author name string

Katrien Vandecasteele

series ordinal

2

1 reference

7 September 2017

Olga Krysko

series ordinal

4

1 reference

7 September 2017

Dmitri V Krysko

series ordinal

5

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 January 2016

1 reference

Advances in Experimental Medicine and Biology

7 September 2017

1 reference

7 September 2017

930

1 reference

7 September 2017

133-149

1 reference

Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production

7 September 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Clearance of apoptotic and necrotic cells and its immunological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

From regulation of dying cell engulfment to development of anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Clearance of dead cells: mechanisms, immune responses and implication in the development of diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Oncogenic properties of apoptotic tumor cells in aggressive B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Immunological aspects of radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

The emergence of phox-ER stress induced immunogenic apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of Damage-Associated Molecular Patterns (DAMPs) in human HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Many faces of DAMPs in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Immunogenic cell death and DAMPs in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Inducers of immunogenic cancer cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Danger signalling during cancer cell death: origins, plasticity and regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Autophagy-dependent ATP release from dying cells via lysosomal exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Molecular mechanisms of ATP secretion during immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Chemotherapy induces ATP release from tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

HMGB1 in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Chemoimmunotherapy: reengineering tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

TNF/TNF-R1 pathway is involved in doxorubicin-induced acute sterile inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

TLR-2 and TLR-9 are sensors of apoptosis in a mouse model of doxorubicin-induced acute inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Radiation oncology: a century of achievements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

A systemic complete response of metastatic melanoma to local radiation and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Immunologic correlates of the abscopal effect in a patient with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

The abscopal effect associated with a systemic anti-melanoma immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Radiotherapy for renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Combining radiotherapy and cancer immunotherapy: a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Radiotherapy and immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Consensus guidelines for the detection of immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Ecto-calreticulin in immunogenic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

gamma-Irradiation induces P2X(7) receptor-dependent ATP release from B16 melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Radiation enhances regulatory T cell representation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

In situ observation of the effects of local irradiation on cytotoxic and regulatory T lymphocytes in cervical cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Immunology's foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Tolerance, danger, and the extended family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Incorporating bortezomib into the treatment of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

CIP2A is a target of bortezomib in human triple negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Primary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Cardiac glycosides exert anticancer effects by inducing immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Induction of immunogenic apoptosis by blockade of epidermal growth factor receptor activation with a specific antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

High hydrostatic pressure induces immunogenic cell death in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

An intact immune system is required for the anticancer activities of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Vaccination with epigenetically treated mesothelioma cells induces immunisation and blocks tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Immunosuppressive effects of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by γδ T lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Effects of Chemoradiation on Tumor-Host Interactions: The Immunologic Side

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Combined treatment of human colorectal tumor cell lines with chemotherapeutic agents and ionizing irradiation can in vitro induce tumor cell death forms with immunogenic potential

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

Correction: Spry1 Is Expressed in Hemangioblasts and Negatively Regulates Primitive Hematopoiesis and Endothelial Cell Function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-39406-0_6

10.1007/978-3-319-39406-0_6

31 March 2020

Identifiers

DOI

1 reference

7 September 2017

1 reference